120 related articles for article (PubMed ID: 18807630)
21. [Menopausal symptoms emerging during hormonal therapy of breast cancer, and their treatment].
Rubovszky G; Horváth Z
Magy Onkol; 2011 Nov; 55(4):235-42. PubMed ID: 22128306
[TBL] [Abstract][Full Text] [Related]
22. The case of the harrowing hot flashes.
Eisenberg S
ONS Connect; 2012 Jun; 27(6):18. PubMed ID: 22774342
[No Abstract] [Full Text] [Related]
23. Pathophysiology and management of hot flashes.
Dalal S; Zhukovsky DS
J Support Oncol; 2006; 4(7):315-20, 325. PubMed ID: 16892692
[TBL] [Abstract][Full Text] [Related]
24. The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer.
Osborne CR; Duncan A; Sedlacek S; Paul D; Holmes F; Vukelja S; Kasper M; Wilks S; Schneider A; McGee R; Meyer WG; O'Shaughnessy JA
Breast Cancer Res Treat; 2009 Aug; 116(3):521-7. PubMed ID: 19139988
[TBL] [Abstract][Full Text] [Related]
25. Ask the doctor. I've been taking tamoxifen for several months after completing treatment for breast cancer. My doctor prescribed it primarily to lower my risk of developing cancer in my unaffected breast. As a result of chemotherapy, I underwent menopause abruptly. Tamoxifen has worsened my symptoms, especially hot flashes and vaginal dryness. Other than stopping the tamoxifen, are there ways to deal with the side effects?
Nicholson CR
Harv Womens Health Watch; 1999 May; 6(9):8. PubMed ID: 10198465
[No Abstract] [Full Text] [Related]
26. Hormone Therapy-Related Hot Flashes and Their Management.
Gupta A
JAMA Oncol; 2018 Apr; 4(4):595. PubMed ID: 29285546
[No Abstract] [Full Text] [Related]
27. Hot flashes in prostate cancer: state of the science.
Engstrom CA
Am J Mens Health; 2008 Jun; 2(2):122-32. PubMed ID: 19477776
[TBL] [Abstract][Full Text] [Related]
28. Inherited gene affects tamoxifen's benefit in some breast cancers.
Mayo Clin Womens Healthsource; 2006 Jun; 10(6):3. PubMed ID: 16675918
[No Abstract] [Full Text] [Related]
29. Breast cancer survivors and hot flashes: the search for nonhormonal treatments.
Avis NE
J Clin Oncol; 2008 Nov; 26(31):5008-10. PubMed ID: 18809600
[No Abstract] [Full Text] [Related]
30. Relationship between hot flashes and distress in men receiving androgen deprivation therapy for prostate cancer.
Ulloa EW; Salup R; Patterson SG; Jacobsen PB
Psychooncology; 2009 Jun; 18(6):598-605. PubMed ID: 18942660
[TBL] [Abstract][Full Text] [Related]
31. Perspectives on the first randomized sham-controlled trial of stellate ganglion block for hot flashes.
Pinkerton JV; Wilson CS
Menopause; 2014 Aug; 21(8):788-91. PubMed ID: 24983275
[No Abstract] [Full Text] [Related]
32. Endocrine symptoms to predict risk of recurrence?
Pritchard KI
Lancet Oncol; 2008 Dec; 9(12):1117-9. PubMed ID: 19038757
[No Abstract] [Full Text] [Related]
33. Hot flashes may be a good sign in women taking tamoxifen.
Mayo Clin Womens Healthsource; 2007 Nov; 11(11):3. PubMed ID: 17898683
[No Abstract] [Full Text] [Related]
34. Magnesium supplements for menopausal hot flashes.
Smith TJ
J Clin Oncol; 2009 Mar; 27(7):1151-2. PubMed ID: 19171696
[No Abstract] [Full Text] [Related]
35. Hypnosis helps reduce hot flashes in breast cancer survivors.
Harv Womens Health Watch; 2009 Feb; 16(6):3. PubMed ID: 19297743
[No Abstract] [Full Text] [Related]
36. Integrative medicine. Oncology: focus on breast cancer.
Glick RM; Desai KM; Lovett E; Farrah R; Low Dog T
FP Essent; 2013 Mar; 406():29-40; quiz 41-6. PubMed ID: 23634463
[No Abstract] [Full Text] [Related]
37. Gene testing to predict tamoxifen-induced hot flashes: new biological insights.
Crandall CJ
J Clin Oncol; 2008 Dec; 26(36):5841-2. PubMed ID: 19018077
[No Abstract] [Full Text] [Related]
38. A unifying theory linking the prolonged efficacy of the stellate ganglion block for the treatment of chronic regional pain syndrome (CRPS), hot flashes, and posttraumatic stress disorder (PTSD).
Lipov EG; Joshi JR; Sanders S; Slavin KV
Med Hypotheses; 2009 Jun; 72(6):657-61. PubMed ID: 19237252
[TBL] [Abstract][Full Text] [Related]
39. Letter to the editor.
Lipov E
Menopause; 2014 Sep; 21(9):1027. PubMed ID: 24937029
[No Abstract] [Full Text] [Related]
40. Response to letter to the editor.
Walega DR; Maki P
Menopause; 2014 Sep; 21(9):1027-8. PubMed ID: 24937028
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
